The goal of the Bioinformatics core is to provide expert computational analysis of molecularprofiling (expression and NMR) data in order to determine the molecular signatures predictive of diagnosisand outcome in Soft Tissue Sarcoma (STS). The core will not only provide computational/statistical analysisbut will build and maintain the data infrastructure needed by the various projects, whose work will lead to thedefinition of new marker sets, mechanistic hypotheses and possible identification of new drug targets. Thecore will also facilitate integration of research in the projects by enabling the sharing of the various datasetscollected. Specifically, it will perform the following tasks. 1) Statistical analysis of microarray expression dataincluding: error analysis, normalization, unsupervised clustering analysis, differential gene analysis andmultivariate class prediction. These methods will be applied in the following cases: a. Cluster and differentialgene expression analysis of sarcoma subtypes to classify sarcoma tissue samples based on their similarityin gene expression, to identify potential diagnostic/prognostic markers and to determine the relevant genesfor subsequent pathway analysis; b. Expression analysis of SYT-SSX regulated genes along with theanalysis of the respective promoters and expression based survival prediction of Synovial Sarcomas; c.Supervised learning analysis of clinical variables such as distant recurrence and survival, the object being togenerate expression based predictors. 2) Statistical analysis of NMR data obtained from Liposarcomasamples, including prediction of Liposarcoma subtypes and sample clinical variables (outcome/survival)using supervised machine learning techniques. Development of integrated (microarray/NMR) molecularprofiling analysis to develop prognostic marker sets. 3) Pathway analysis of molecular profiling data.Integrating data from (1) and (2) with pathway data to: a. Elucidate the biological basis of tumor subtypes; b.Find new potential drug targets. 4) To develop an online repository of microarray expression data along witha database of annotation information and clinical data. Integrate and make available the large collection ofdatasets to be collected. 5) To develop a patient data tracking system for multi-institutional clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA047179-15A2
Application #
7141207
Study Section
Subcommittee G - Education (NCI)
Project Start
2006-07-01
Project End
2011-06-30
Budget Start
2006-07-17
Budget End
2007-06-30
Support Year
15
Fiscal Year
2006
Total Cost
$126,336
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Xie, Yuanyuan; Cao, Zhen; Wong, Elissa Wp et al. (2018) COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors. J Clin Invest 128:1442-1457
Weinreb, Ilan; Bishop, Justin A; Chiosea, Simion I et al. (2018) Recurrent RET Gene Rearrangements in Intraductal Carcinomas of Salivary Gland. Am J Surg Pathol 42:442-452
Kao, Yu-Chien; Sung, Yun-Shao; Zhang, Lei et al. (2017) Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP-BCORL1 and KDM2A-WWTR1. Genes Chromosomes Cancer 56:42-50
Seifert, Adrian M; Zeng, Shan; Zhang, Jennifer Q et al. (2017) PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clin Cancer Res 23:454-465
Argani, Pedram; Zhang, Lei; Reuter, Victor E et al. (2017) RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH. Am J Surg Pathol 41:655-662
Argani, Pedram; Zhong, Minghao; Reuter, Victor E et al. (2016) TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers. Am J Surg Pathol 40:723-37
Tan, Marcus C B; Brennan, Murray F; Kuk, Deborah et al. (2016) Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma. Ann Surg 263:593-600
Specht, Katja; Zhang, Lei; Sung, Yun-Shao et al. (2016) Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas. Am J Surg Pathol 40:433-42
Huang, Shih-Chiang; Ghossein, Ronald A; Bishop, Justin A et al. (2016) Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation. Am J Surg Pathol 40:51-9
Dickson, Mark A; Schwartz, Gary K; Keohan, Mary Louise et al. (2016) Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial. JAMA Oncol 2:937-40

Showing the most recent 10 out of 336 publications